Assessment of biochemical determinants in Multiple Sclerosis patients following the oral administration of β-D-Mannuronic acid [M2000].

CONCLUSIONS: Our results suggested that β-D-Mannuronic acid is a safe drug and has no toxicity when administered orally and also has some therapeutic effects in MS patients.
PMID: 32964823 [PubMed - as supplied by publisher]

Source: Current Drug Discovery Technologies - September 16, 2020 Category: Drugs & Pharmacology Authors: Nikouei Moghaddam MR, Movahedi M, Bananej M, Najafi S, Moghadam NB, Saadat P, Mokhtarian F, Mirshafiey A Tags: Curr Drug Discov Technol Source Type: research